Amarin (AMRN) Announces sNDA Submission for BASF as additional Vascepa Supplier
Tweet Send to a Friend
Amarin Corporation plc (Nasdaq: AMRN) announced today the late December 2012 submission of a Supplemental New Drug Application (sNDA) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
